Company

Hanmi Pharm. Co. Ltd

Headquarters: Seoul, South Korea

Employees: 2,155

CEO: Mr. Jong-Soo Woo Ph.D.

KRX: 128940 +8.83%

Market Cap

₩3.633 Trillion

KRW as of July 1, 2025

US$2.68 Billion

Market Cap History

Hanmi Pharm. Co. Ltd Categories

South Korea Healthcare Drug Manufacturers—Specialty & Generic
South Korea Healthcare South Korea Drug Manufacturers—Specialty & Generic

Hanmi Pharm. Co. Ltd market capitalization over time

Evolution of Hanmi Pharm. Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Hanmi Pharm. Co. Ltd

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector:
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Detailed Description

Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.

Financials

Last Financial Reports Date March 31, 2025
Revenue TTM ₩1.483 T
EBITDA ₩419.56 B
Gross Profit TTM ₩804.14 B
Profit Margin 7.35%
Operating Margin 15.10%
Quarterly Revenue Growth -3.20%
Financial Reports & Statistics

Stocks & Indices

Hanmi Pharm. Co. Ltd has the following listings and related stock indices.


Stock: KRX: 128940 wb_incandescent

Details

Headquarters:

14, Wiryeseong-daero

Songpa-gu

Seoul, 05545

South Korea

Phone: 82 2 410 9114

Fax: 82 2 410 9259